Colgate-Palmolive (NYSE:CL) Shares Sold by Redhawk Wealth Advisors Inc.

Redhawk Wealth Advisors Inc. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 7.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,338 shares of the company’s stock after selling 447 shares during the period. Redhawk Wealth Advisors Inc.’s holdings in Colgate-Palmolive were worth $500,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth about $27,000. Vermillion Wealth Management Inc. acquired a new position in Colgate-Palmolive during the fourth quarter worth about $31,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the fourth quarter worth about $32,000. Finally, Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive during the fourth quarter worth about $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CL. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a report on Wednesday, April 2nd. Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. UBS Group lifted their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a report on Thursday, April 17th. Barclays lowered their target price on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a report on Friday, April 11th. Finally, Citigroup lifted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a “buy” rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $102.12.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.1%

Shares of NYSE CL opened at $92.02 on Thursday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm has a market capitalization of $74.57 billion, a PE ratio of 26.14, a PEG ratio of 4.20 and a beta of 0.38. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The business has a 50-day moving average price of $91.64 and a two-hundred day moving average price of $91.13.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm’s revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS. As a group, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.26%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Thursday, April 17th. Colgate-Palmolive’s payout ratio is currently 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a stock buyback plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.